Sila Realty Trust: High-Yield Healthcare REIT Still Trading At A Discount

IWA Research2.48K FollowersFollow5ShareSavePlay(9min)Comment(1)SummarySila Realty Trust remains a Buy, offering a strong, sustainable dividend yield and trading at a substantial discount to intrinsic value.SILA reported a ~98.7% leased rate, a 10-year weighted average lease term, and AFFO of $120.91 million in 2025, supporting its $0.40 quarterly dividend and even potential future hikes.Management highlighted the potential to see $225–$375 million in investments for 2026, maintaining prudent leverage and flexibility amid macroeconomic headwinds and high rates.Despite macro risks, SILA’s necessity-based healthcare real estate, disciplined capital allocation, and long-term focus underpin its resilience and reliable growth. Tom Werner/DigitalVision via Getty Images Introduction The last time I covered Sila Realty Trust (SILA), I highlighted this healthcare REIT’s high and sustainable dividend yield, backed by strong fundamentals and a substantial discount to intrinsic value, with the latest report at that time beating theThis article was written byIWA Research2.48K FollowersFollowI've been researching companies in-depth for over a decade, from commodities like oil, natural gas, gold and copper to tech like Google or Nokia and many emerging market stocks, which I believe could help me provide useful content for readers. After writing my own blog for about 3 years, I decided to switch to a value investing-focused YouTube channel, where I researched hundreds of different companies so far. I would say my favorite type of company to cover are metals and mining stocks, but I am comfortable with several other industries, such as consumer discretionary/staples, REITs and utilities.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in SILA over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.